BioCentury
ARTICLE | Financial News

Dezima raises EUR 14.2 million

March 1, 2013 2:49 AM UTC

Dezima Pharma B.V. (Naarden, the Netherlands) raised EUR 14.2 million ($18.8 million) comprising a EUR 9.8 million ($13 million) series A round and a EUR 4.4 million ($5.8 million) loan. Forbion Capital Partners and BioGeneration Ventures led Dezima's A round, and New Science Ventures also participated. The loan was from an agency of the Dutch Ministry of Economic Affairs. Forbion's Marco Boorsma, New Science Ventures' Somu Subramaniam and BioGeneration's Wil Hazenberg will join Dezima's board. ...